U.S. market Closed. Opens in 1 day 3 hours 15 minutes

ONCS | OncoSec Medical Incorporated Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-07-312021-07-312020-07-312019-07-312018-07-31
RevenueN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/A
Operating Expenses37.01M48.38M43.41M30.42M36.11M
Selling, General & Admin11.19M14.28M18.31M11.97M18.69M
Research & Development25.82M34.10M25.10M18.45M17.42M
Other Operating Expenses28.86K-704.00185.05K440.04KN/A
Operating Income-37.01M-48.38M-43.41M-30.42M-36.11M
Other Expenses / Income-501.72K800.14K283.07K141.92K-3.03M
Before Tax Income-37.51M-47.58M-43.13M-30.27M-39.14M
Income Tax Expenses-3.33M-2.41M-872.59K1.30K680.00
Net Income-34.18M-45.17M-42.25M-30.28M-39.14M
Interest Expenses20.93K15.86K5.11K3.81K6.37M
Basic Shares Outstanding1.79M1.50M751.57K320.60K182.38K
Diluted Shares Outstanding1.79M1.50M751.57K320.60K182.38K
EBITDA-35.92M-47.30M-42.23M-29.73M-32.43M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-37.49M-47.56M-43.12M-30.27M-32.76M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-07-312021-07-312020-07-312019-07-312018-07-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙